In terms of imaging of prostate cancer, elevated uptake in normal PSMA-expressing organs may lead to non-optimal target/background ratios, likely resulting in lower imaging contrast and the underestimation of oligometastases. The gene discussed is FOLH1; the disease is prostate cancer.